News
Press releases
- Alia Therapeutics appoints Adel Nada as Independent Board Director – Sofinnova Partners
- Alia Therapeutics names Letizia Goretti as Chief Executive Officer – Sofinnova Partners
- Alia Therapeutics secures €4.4 million seed financing extension led by Sofinnova Partners – Sofinnova Partners
- Sofinnova Partners announces three new investments from its fund dedicated to Italian scientific research – Sofinnova Partners
- Alia Therapeutics closes its seed funding round – BiovelocITA